Breast Cancer Research

Prevention Study

The National Surgical Adjuvant Breast and Bowel Project (NSABP) is a clinical trials cooperative group supported by the National Cancer Institute (NCI).

The Study of Tamoxifen and Raloxifene, or STAR, is one of the largest breast cancer prevention studies ever. This five year study aims to recruit 22,000 volunteers at more than 400 centers across the United States, Puerto Rico, and Canada.

Call DMH Health Research at 217-876-6610 for more information about this study.

Call the Clinical Research Department at DMH (217-876-6615) for information on Treatment Trials or consult your physician to discuss appropriate trials.

Frequently Asked Question of STAR

Also, www.ClinicalTrials.gov can be used to access information about clinical trials related to breast cancer.

302 West Hay, Suite 117A
Office Hours: 8:00a.m. - 4:30p.m. Monday - Friday
217-876-4377
Fax: 217-876-4374
Email: Pamela McMillen, R.N., B.S.N.
Email: Heather Ludwig, R.N., B.S.N.

Back to Women's Health & Breast Center

	SEARCH